Zobrazeno 1 - 10
of 444
pro vyhledávání: '"Prescribing information"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Безопасность и риск фармакотерапии, Vol 8, Iss 2, Pp 104-106 (2020)
Experts of the Department for Evaluation of Medicinal Products’ Safety of the Scientific Centre for Expert Evaluation of Medicinal Products analysed administrative decisions of foreign regulatory authorities on the recall of medicines and/or the ne
Externí odkaz:
https://doaj.org/article/cbd2a92ef9204b9ebbe3e319342349df
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Gosselin, R C, Favaloro, E J & Douxfils, J 2022, ' The Myths Behind DOAC Measurement : Analyses of Prescribing Information from Different Regulatory Bodies and a Call for Harmonization ', Journal of thrombosis and haemostasis : JTH, vol. 20, no. 11, pp. 2494-2506 . https://doi.org/10.1111/jth.15884
For more than a decade, US laboratories have failed to implement solutions to help their clinicians in managing complex situations or patients on direct oral anticoagulants (DOACs). The problem may find different origins, among which is the position
Autor:
Kate Ferriola-Bruckenstein, Mihaela Johnson, Janice Tzeng, Ann Marie Trentacosti, Kathryn J. Aikin, Eric Brodsky, Helen Sullivan, Claudia Squire
Publikováno v:
Res Social Adm Pharm
Background The Prescribing Information (PI) is the US Food and Drug Administration (FDA)'s primary tool for communicating a summary of the essential scientific information needed for the safe and effective use of a prescription drug to healthcare pro
Autor:
Rianne A. Weersink, Lotte Timmermans, Margje H. Monster-Simons, Peter G. M. Mol, Herold J. Metselaar, Sander D. Borgsteede, Katja Taxis
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Background: In 2005, the European Medicines Agency (EMA) released guidance on pharmacokinetic studies in patients with hepatic impairment. This guidance describes the design of these studies and what information should be presented in the Summary of
Externí odkaz:
https://doaj.org/article/6f6771123d4a4411a95cfa69ca5907d9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the Medical Library Association, Vol 106, Iss 3 (2018)
Objectives: The research compared the comprehensiveness and accuracy of two online resources that provide drug information: Lexicomp and Wikipedia. Methods: Medication information on five commonly prescribed medications was identified and comparisons
Externí odkaz:
https://doaj.org/article/ccc21e32a65c44b0975bc71c61ef1c33
Publikováno v:
European Journal of Clinical Pharmacology. 78:419-434
Purpose In aut-idem or generic substitution, discrepancies between summaries of product characteristics (SmPCs) referring to the same active substance (AS) may cause difficulties regarding informed consent and medical liability. The qualitative and q
Autor:
Erin K. Crowley, Caroline Hynes, Jean O'Connell, Stephen McWilliams, Dolores Keating, Ita Fitzgerald
Publikováno v:
Evidence-Based Mental Health
BackgroundAdjunctive metformin is the most well-studied intervention in the pharmacological management of antipsychotic-induced weight gain (AIWG). Although a relatively unaddressed area, among guidelines recommending consideration of metformin, pres